Partner-based yoga program for head and neck cancer patients and their caregivers
Improving Healthcare Utilization and Quality of Life in Head and Neck Cancer Patients Undergoing Chemoradiation and Their Family Caregivers
This study tests whether a partner-based yoga program can help improve the quality of life for head and neck cancer patients and their caregivers during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04890834 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a dyadic yoga intervention aimed at improving the quality of life for patients with head and neck cancer undergoing chemoradiation and their caregivers. Participants will be randomized into two groups: one receiving standard care and the other participating in the yoga program. The study will assess healthcare utilization, including emergency department visits and feeding tube insertions, as well as overall quality of life improvements. Additionally, the cost-effectiveness of the intervention will be analyzed, along with qualitative insights into patient and caregiver experiences.
Who should consider this trial
Good fit: Ideal candidates include adults diagnosed with head and neck cancer who are about to undergo chemoradiation and have a willing family caregiver.
Not a fit: Patients who have participated in a yoga program in the year prior to their diagnosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance the quality of life for both patients and caregivers while potentially reducing healthcare costs.
How similar studies have performed: Other studies have shown positive outcomes with yoga interventions in cancer care, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * PATIENTS: Diagnosed with a primary HNC and going to receive at least 5 weeks (25 fractions) of CRT * PATIENTS: Eastern Cooperative Oncology Group (ECOG) performance status of =\< 2 * PATIENTS: Having a family caregiver (e.g., spouse/partner, sibling, adult child) willing to participate * PATIENTS AND CAREGIVERS: Must be at least 18 years old * PATIENTS AND CAREGIVERS: Able to read and speak English * PATIENTS AND CAREGIVERS: Able to provide informed consent Exclusion Criteria: * PATIENTS AND CAREGIVERS: Who have regularly (self-defined) participated in a yoga program in the year prior to diagnosis
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Kathrin Milbury — M.D. Anderson Cancer Center
- Study coordinator: Kathrin Milbury
- Email: kmilbury@mdanderson.org
- Phone: 713-745-2868
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.